Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Infusion Pump Market by Product (Accessories (Dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory, Enteral)) Technology (Traditional, Specialty) Application (Cancer, Diabetes, Pediatric) & Setting (Hospital, Home care) - Global Forecast to 2027
... expected to reach USD 20.5 Billion by 2027 from an estimated USD 14.7 Billion in 2022, at a CAGR of 7.0%. Factors such as the increasing incidence of chronic diseases along with the rapid growth ... Read More
-
Digital Diabetes Management Market Analysis And Forecast To 2031: By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, Apps), By Type (Wearable Devices, Handheld Devices), By End-use (Hospital, Home settings, Diagnostic Centers), And Region
... Home settings, Diagnostic Centers), And Region The global digital diabetes management market was valued at USD 14.8 Billion in 2021 and it is anticipated to grow up to USD 71.9 Billion by 2031, at a ... Read More
-
Auto-injectors Market, by Product Type (Prefilled Auto-injectors, Fillable Auto-injectors), by Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others (Diabetes, Psoriasis, etc.)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to ... Read More
-
Autoimmune Disease Diagnostics Market Analysis And Forecast To 2031: By Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis, Others), By End-use (Hospitals, Diagnostics Centers, Others), And Region
... By End-use (Hospitals, Diagnostics Centers, Others), And Region The global autoimmune disease diagnostics market was valued at USD 1.3 billion in 2021 and it is anticipated to grow up to USD 3.1 billion by 2031, ... Read More
-
Global Remote Patient Monitoring Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 By Component Type (Devices, and Software & Services), Product (Vital Sign Monitors, and Special Monitors), Application (Cancer, Cardiovascular Diseases(CVD), Diabetes, Sleep Disorder, Weight management & Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, and Hypertension), End-User (Hospitals & Clinics, Home Care Settings & Long Term Care Centre’s, Ambulatory Care Centre’s, Passive Exoskeletons, Payers, and Patients) and Region (North America, Europe, Asia Pacific, Latin America Middle East, and Africa (LAMEA))
... management & Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, and Hypertension), End-User (Hospitals & Clinics, Home Care Settings & Long Term Care Centre’s, Ambulatory Care Centre’s, Passive Exoskeletons, Payers, and Patients) and Region (North America, Europe, ... Read More
-
Global Metabolomics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product and Services (Metabolomics Instrument, Metabolomics bioinformatics tools and services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Metabolic Disorders), Application (Biomarker Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
... Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Market Overview: The scientific study of chemical processes, including metabolites, is known as ... Read More
-
Global Home-Care Monitoring and Diagnostics Market Research Report 2022-2032
... Forecasts to 2031 which is anticipated to reach Market Value According to a study by Fatpos Global. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, ... Read More
-
Diabetic Retinopathy - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
SAUDI ARABIA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The market is estimated to reach a value of more than USD 2.8 billion by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in Saudi Arabia. Patients with diabetes, infected with ... Read More
-
AUSTRALIA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027 and is estimated to reach around USD 758 million by 2027. The COVID-19 pandemic positively impacted the Australia Diabetes Care Devices Market growth. Patients with diabetes, infected with COVID-19 may experience elevated blood glucose, ... Read More
-
CHINA DIABETES DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO in January 2020 COVID -19 deaths, there are 20% of people with diabetes and diabetes-related diseases happened in China. Nearly one in ten COVID-19 patients have diabetes in China. Diabetes is associated with a ... Read More
-
CANADA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... has 107,861 cases of coronavirus disease 2019 (COVID-19) (286 per 1,00,000 individuals) and 8787 COVID-19-related fatalities as of July 13, 2020. In Canada, public health is overseen at the federal, provincial, and regional levels, and ... Read More
-
GERMANY DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Most people who have died of COVID-19 were affected by the co-occurrence of two or more ... Read More
-
INDONESIA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... coronavirus disease 2019 (COVID-19) pandemic is a massive worldwide public health disaster caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 has a wide clinical range, with symptoms ranging from asymptomatic to ... Read More
-
SOUTH AFRICA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... forecast period 2022-2027 and is estimated to reach around USD 172 million by 2027. The COVID-19 pandemic positively impacted the South Africa Diabetes Care Devices Market growth. Patients with diabetes, infected with COVID-19 may experience ... Read More
-
Middle East and Africa Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... than 5% during the forecast period of 2022-2027. The market is estimated to reach a value of more than USD 47 million by 2027. The COVID-19 pandemic positively impacted the Insulin Infusion Pumps market growth ... Read More
-
ASIA-PACIFIC INSULIN SYRINGE MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... estimated to reach around USD 1 billion by 2027. India holds the highest market share in the Asia-Pacific Insulin Syringe Market and is expected to register a CAGR of more than 1.4% in the forecast ... Read More
-
BRAZIL DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Most people who have died of COVID-19 were affected by the co-occurrence of two or more ... Read More
-
VIETNAM DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... Among the nations affected by the COVID-19 epidemic, Vietnam has effectively stopped transmission since the beginning, with no deaths for months. However, the fourth wave of the COVID-19 epidemic has been wreaking havoc on Vietnam ... Read More
-
MALAYSIA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... The Malaysian Ministry of Health announced that the Southeast Asian nation recorded 5,809 new COVID-19 cases in 24 hours, including 5,782 domestically infected and 27 imported ones, bringing the national tally to 2,541,147. So far, ... Read More
-
DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... billion by 2027, registering a CAGR of over 5% during 2022- 2027 (henceforth, referred to as the ‘forecast period’). The COVID-19 pandemic has substantially impacted the diabetes care devices market. The prevalence of diabetes in ... Read More
-
PHILIPPINES DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... COVID-19 is a new illness caused by a strain of the SARS-CoV-2 virus. Most patients infected with the virus will develop mild to moderate respiratory disease and will recover without the need for special care. ... Read More
-
IRAN DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... most significant challenges of diabetes care management in developing countries during the COVID-19 pandemic include inadequate preventive measures, interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic care, and a ... Read More
-
Asia-Pacific Meglitinide Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)
... statistically greater incidence of type 2 diabetes and other kinds of diabetes in the Asia-Pacific region. Individuals with no history of diabetes who recovered from SARS-CoV-2 infections have been reported to develop insulin resistance and ... Read More
-
North America Glucagon-Like Peptide-1 (GLP-1) Agonists Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... during the forecast period 2022-2027. The COVID-19 pandemic positively impacted a few segments of the North American Glucagon-like Peptide-1 (GLP-1) Agonists Market. Diabetes and uncontrolled hyperglycemia are risk factors for poor outcomes in patients with ... Read More
Research Assistance
